Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Elevance Health, Inc. Director's Dealing 2012

Mar 5, 2012

29933_dirs_2012-03-05_de1d112e-75b1-4b72-aa0d-2e4c75e0b50e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WELLPOINT, INC (WLP)
CIK: 0001156039
Period of Report: 2012-03-01

Reporting Person: MCCARTHY GLORIA M (EVP, Office of the CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-03-01 Common Stock A 11367 Acquired 59600.1293 Direct
2012-03-01 Common Stock A 6795 Acquired 66395.1293 Direct
2012-03-01 Common Stock F 3766 $66.23 Disposed 62629.1293 Direct
2012-03-02 Common Stock F 4954 $65.78 Disposed 57675.1293 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-03-01 Employee Stock Option (Right to Buy) $66.23 A 18506 Acquired 2019-03-01 Common Stock (18506) Direct

Footnotes

F1: Represents performance based restricted share units. Restrictions lapse as follows: 3,789 each on 3/1/12, 12/10/12 and 3/1/14.

F2: Represents restricted share units. Restrictions lapse as follows: 2,265 each on 12/10/12, 3/1/14 and 3/1/15.

F3: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

F4: Exercisable in four installments of 3,084 each on 9/1/12, 3/1/13, 9/1/13, 3/1/14, and two installments of 3,085 each on 9/1/14 and 3/1/15.